Alexa
  • Directory of Taiwan

Global & U.S. Chemotherapy Induced Peripheral Neuropathy Market 2022: Segmentation Analysis, Business Opportunities, Top Players, Prominent Regions and Forecast to 2030

The Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market held a market value of USD 1,613.8 Million in 2020 and is forecasted to reach USD 2,373.1 Million by the year 2027. The market is anticipated to register a CAGR of 5.7% over the projected period.

Request Sample PDF of the Report –
https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

The Centers for Medicare and Medicaid Services report that US healthcare expenditures grew by 4.6% to US$ 3.8 trillion in 2019, or US$ 11,582 per person, and accounted for 17.7% of GDP. Also, the federal government accounted for 29.0% of the total health expenditures, followed by households (28.4%). State and local governments accounted for 16.1% of total health care expenditures, while otherI private revenues accounted for 7.5%.

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Request Sample Report here:
https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

Chemotherapy Induced Peripheral Neuropathy is a side effect caused by antineoplastic agent. It is one of the most frequent side effects and is a mostly sensory neuropathy which might be accompanied by autonomic and motor changes of varying duration and intensity. Growing prevalence of cancer along with increasing cases of CIPN is anticipated to boost the market growth. Furthermore, technological advancements coupled with rising demand for cost-efficient therapeutics is also expected to fuel the market growth. Despite the driving factors, adverse effects related to cancer treatment are expected to hinder the market growth during the forecast period. The overall impact of COVID-19 is neutral as the after effects of chemotherapy can be very severe and adoption of telehealth solutions made it possible for patients to consult their doctors and start their treatment.

Growth Influencers:
Growing prevalence of cancer along with increasing cases of CIPN
Prevalence of cancer is rising globally, which is also leading to growing cases of chemotherapy induced peripheral neuropathy. According to the National Cancer Institute, as of 2020, approximately 1,806,590 new cancer cases were expected to be diagnosed in the United States. Furthermore, according to American Cancer Society, in 2021, about 1.9 million cancer cases were estimated to be diagnosed and 608,570 people were expected to die in the United States. These rising number of cancer cases are leading to high adoption of various treatment options of cancer. These treatment options include chemotherapy as well.

Get Sample Report + All Related Graphs & Charts @
https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

Segments Overview:
The Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market is segmented the type and application.

By Type,
Calcium Channel A2-Delta Ligands
Antidepressants
Opioids
Others
The calcium channel A2-delta ligands segment is anticipated to hold the largest market share of around 34.7% owing to high adoption of calcium channel A2-delta ligands for the treatment of CIPN. The opioids segment is expected to grow at the fastest rate of around 6.7% owing to the growing number of research activities by market players for the development of opioids.

By Application,
Platinum Agents
Taxanes
Vinca Alkaloids
Others
The platinum agents segment is estimated to account for the largest market share of 33.7% and is expected to surpass a market value of USD 667.7 million by 2024. The taxanes segment is expected to witness the fastest growth rate of 6.5% owing to high usage of taxanes for breast cancer induced CIPN.

Regional Overview
Based on region, the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market is divided into Europe, North America, Asia-Pacific, Middle East, Africa, and South America.

Request To Download Sample of This Strategic Report:-
https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

The North America region is expected to hold the largest market share of around 36.2% owing to the high prevalence of cancer in the region. The region is expected to cross a market value of USD 640.7 million by 2022
The Asia Pacific region is anticipated to witness the fastest growth rate of 6.8% owing to the growing R&D activities in the region. The Europe region is estimated to surpass a market value of USD 548.4 million by 2023.

Competitive Landscape
Key players operating in the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market include Asahi Kasei Pharma Corp, Aptinyx Inc., Regenacy Pharmaceuticals, MAKScientific LLC, Metys Pharmaceuticals AG, Nemus Bioscience Inc., PledPharma, Sova Pharmaceuticals Inc., DermaXon LLC, Kineta Inc., PeriphaGen, Apexian Pharma, and WinSanTor, among others.

These market players are engaged in mergers & acquisitions, collaborations, and new product launches to strengthen their market presence. For instance, in December 2019, Solasia Pharma KK, the Asian partner of PledPharma AB signed a licensing agreement with Maruho Co Ltd, a Japan-based pharmaceutical company for commercialization of PledOx for treatment of CIPN in Japan.

Table Of Content: Chapter 1. Research Framework
1.1. Objective
1.2. Product Overview
1.2.1. Market Segmentation
1.2.2. Market & Segment Definitions
1.3. Research Methodology
1.3.1. List of Primary & Secondary Sources
1.3.2. Market Size Estimation
1.3.2.1. Assumption for the Study
1.3.2.2. Data Triangulation
2.4 Assumption for the Study
2.5 Market Size Estimation
Chapter 2. Executive Summary: Global Chemotherapy Induced Peripheral Neuropathy Treatment Market
Chapter 3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview
3.1. Industry Value Chain Analysis
3.1.1. Raw Material Provider
3.1.2. Manufacturing
3.1.3. Packaging and Distribution ……..and view more in complete table of Contents

Get a Free Sample Report
https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

The Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market report provides insights on the below pointers:

Market Penetration: Provides comprehensive information on the market offered by the prominent players
Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment market report answers questions such as:

What is the market size and forecast of the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market
What are the inhibiting factors and impact of COVID-19 on the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market during the assessment period
Which are the products/segments/applications/areas to invest in over the assessment period in the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market
What is the competitive strategic window for opportunities in the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market
What are the technology trends and regulatory frameworks in the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market
What is the market share of the leading players in the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market
What modes and strategic moves are considered favorable for entering the Global & U.S. Chemotherapy Induced Peripheral Neuropathy Treatment Market

Get 20% Off On Various License Types When Buy Now At:

https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.

Reports on the market include the growth rates of each region, which includes their countries, over the coming years.

How are the key players in the market assessed?

This report provides a comprehensive analysis of leading competitors in the market.

The report includes information about the key vendors in the market.

The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.

The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.

A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Download Free Sample Report, SPECIAL OFFER (Avail an Up-to 20% discount on this report-
https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

What factors are taken into consideration when assessing the key market players?

The report analyzes companies across the globe in detail.

The report provides an overview of major vendors in the market, including key players.

Reports include information about each manufacturer, such as profiles, revenue, product pricing, and other pertinent information about the manufactured products.

This report includes a comparison of market competitors and a discussion of the standpoints of the major players.

Market reports provide information regarding recent developments, mergers, and acquisitions involving key players.

What are the key findings of the report?

This report provides comprehensive information on factors expected to influence the market growth and market share in the future.

The report offers the current state of the market and future prospects for various geographical regions.

This report provides both qualitative and quantitative information about the competitive landscape of the market.

Combined with Porter’s Five Forces analysis, it serves as SWOT analysis and competitive landscape analysis.

It provides an in-depth analysis of the market, highlighting its growth rates and opportunities for growth.

Access full Report Description, TOC, Table of Figure, Chart, etc. @

https://reportocean.com/industry-verticals/sample-request?report_id=ARS196

Browse some more reports:

About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/


Updated : 2022-01-25 16:35 GMT+08:00

"